We transform clinical potential into commercial success by providing comprehensive medical communications support, digital solutions, strategic counsel, and tactical execution throughout the brand life cycle. The relationships we form with our partners, both clients and HCPs alike, are deeply valued.
OUR APPROACH:
FIRST: Identify and engage directly with KOLs on an ongoing basis to establish the client as a committed partner in this disease state, gather insights about the market and therapeutic landscape, and uncover unmet needs.
NEXT: Partner with KOLs and speakers to build a compelling story and educate on the product’s novel MOA, unique route of administration, and robust efficacy data.
THEN: Pre-emptively manage the understanding of the product’s safety profile through novel dual speaker programs to set accurate expectations and ensure comfort with its use.
FINALLY: Deploy continuously evolving speaker programs and other innovative content experiences to a variety of stakeholders—MDs, PAs/NPs, RNs, and patients—while continuing to learn and support the market.
PRIMARY: Achieved a 15:1 ROI through the use of dual speaker programs (compared to 8:1 for other programs) and successfully educated all key stakeholders on the product’s efficacy and safety.
SECONDARY: Established our client as a trusted partner and leader in the neurology space.
“For this launch, PRECISIONscientia was a top shelf agency—really valuable medical communications partner—strong science (they had me working with PharmDs and PhDs), solid on strategy. I highly endorse them.”
– Director of Marketing
New to the space, our client sought support in preparation of their US launch of the first and only targeted treatment for a rare, hard-to-treat malignancy.
OUR APPROACH:
PRIMARY: Establishment of a strong, consistently communicated scientific foundation that set our client up for a successful launch in the US, as well as globally.
SECONDARY: Secured client’s position as a committed leader in the space.
BONUS: The product received FDA priority review and was approved as the first and only therapy for this rare disease.
OUR APPROACH:
FIRST: Dive deep into considerable research, data, and case studies to create an overall Training Road Map that will inspire and inform MSLs.
NEXT: Develop high-impact curriculum using animated PowerPoint with key takeaways, as well as traditional and confidence assessments.
THEN: Organize peer-to-peer study halls, create a virtual environment where MSLs can interact with HCPs, and pressure-test their understanding of the curriculum.
FINALLY: Execute a certification workshop that assesses MSLs not only on their foundational knowledge, but also on their ability to present new knowledge confidently and accurately in the real world.
PRIMARY: Preparation of a strong, educated MSL team ready to communicate information on disease state, as well as the value of the product.
SECONDARY: By illuminating areas for improvement (such as presentation and virtual interaction skills), PRECISIONscientia was able to support MSLs in mastering the development of peer-to-peer relationships with HCPs.
BONUS To keep their momentum going, our
clients retained us to work with their MSL team
as they neared their first-ever product launch.
We transform clinical potential into commercial success by providing comprehensive medical communications support, digital solutions, strategic counsel, and tactical execution throughout the brand life cycle. The relationships we form with our partners, both clients and HCPs alike, are deeply valued.
OUR APPROACH:
FIRST: Identify and engage directly with KOLs on an ongoing basis to establish the client as a committed partner in this disease state, gather insights about the market and therapeutic landscape, and uncover unmet needs.
NEXT: Partner with KOLs and speakers to build a compelling story and educate on the product’s novel MOA, unique route of administration, and robust efficacy data.
THEN: Pre-emptively manage the understanding of the product’s safety profile through novel dual speaker programs to set accurate expectations and ensure comfort with its use.
FINALLY: Deploy continuously evolving speaker programs and other innovative content experiences to a variety of stakeholders—MDs, PAs/NPs, RNs, and patients—while continuing to learn and support the market.
PRIMARY: Achieved a 15:1 ROI through the use of dual speaker programs (compared to 8:1 for other programs) and successfully educated all key stakeholders on the product’s efficacy and safety.
SECONDARY: Established our client as a trusted partner and leader in the neurology space.
“For this launch, PRECISIONscientia was a top shelf agency—really valuable medical communications partner—strong science (they had me working with PharmDs and PhDs), solid on strategy. I highly endorse them.”
– Director of Marketing
New to the space, our client sought support in preparation of their US launch of the first and only targeted treatment for a rare, hard-to-treat malignancy.
OUR APPROACH:
PRIMARY: Establishment of a strong, consistently communicated scientific foundation that set our client up for a successful launch in the US, as well as globally.
SECONDARY: Secured client’s position as a committed leader in the space.
BONUS: The product received FDA priority review and was approved as the first and only therapy for this rare disease.
OUR APPROACH:
FIRST: Dive deep into considerable research, data, and case studies to create an overall Training Road Map that will inspire and inform MSLs.
NEXT: Develop high-impact curriculum using animated PowerPoint with key takeaways, as well as traditional and confidence assessments.
THEN: Organize peer-to-peer study halls, create a virtual environment where MSLs can interact with HCPs, and pressure-test their understanding of the curriculum.
FINALLY: Execute a certification workshop that assesses MSLs not only on their foundational knowledge, but also on their ability to present new knowledge confidently and accurately in the real world.
PRIMARY: Preparation of a strong, educated MSL team ready to communicate information on disease state, as well as the value of the product.
SECONDARY: By illuminating areas for improvement (such as presentation and virtual interaction skills), PRECISIONscientia was able to support MSLs in mastering the development of peer-to-peer relationships with HCPs.
BONUS To keep their momentum going, our
clients retained us to work with their MSL team
as they neared their first-ever product launch.
© 2020 PRECISIONSCIENTIA, INC. A PRECISION MEDICINE
GROUP COMPANY. ALL RIGHTS RESERVED. Privacy Policy GDPR